FDA grants accelerated approval to new treatment for advanced ovarian cancer. Press release. December 19, 2016.FDA News Release. FDA grants accelerated approval to new treat- ment for advanced ovarian cancer. Available at: http://www.fda. gov/NewsEvents/Newsroom/PressAnnouncements/ucm533873. htm...
Grants or any other funding The Declaration of Interests tool should always be completed. Authors with no competing interests to declare should select the option, "I have nothing to declare". The resulting Word document containing your declaration should be uploaded at the "attach/upload files" st...
It is not uncommon for employers and co-workers to have misperceptions about an individual’s ability to work during and after undergoing treatment for cancer [1]. One in four individuals with cancer faces some form of discrimination in the workplace [2, 3]. In the United States, federal ...
11 Therefore, we examined the association between hospital type (NCI center vs community hospital) and insurer spending and care utilization during a surgical episode for patients with private insurance who underwent common cancer surgery. We hypothesized that treatment at NCI centers, compared with ...
by age, race/ethnicity, stage, molecular subtype, and geography based on incidence data through 2019 and mortality data through 2020; relative survival for persons diagnosed during 2012–2018 and followed through 2019 by stage at diagnosis and breast cancer subtype; and treatment patterns in 2018....
Moreover, because patients are more susceptible to infections during adjuvant breast cancer treatment, for them to accomplish the types and doses of PA needed to achieve the intended effect, the interventions must be performed within secure and trustworthy settings, also regarding the risk of ...
For patients with locally advanced rectal cancer (LARC), neoadjuvant chemoradiotherapy (NACRT) is a standard treatment that can improve the outcomes of radical resection, prevent local recurrence, ensure sphincter preservation and tolerable toxicity levels, and maintain postsurgical quality of life [15,...
1 However, early-stage lung cancer has a better prognosis and is more amenable to treatment. USPSTF Assessment of Magnitude of Net Benefit The US Preventive Services Task Force (USPSTF) concludes with moderate certainty that annual screening for lung cancer with LDCT has a moderate net benefit ...
“Today’s action can provide an important public health tool that offers individuals more information about their health, including possible predisposition for certain cancers, which can help guide physicians to provide appropriate monitoring and potential therapy, based on discovered va...
We also introduce the biomarkers associated with telomeres, telomerase and pancreatic cancer, and how telomerase may be targeted for the treatment of pancreatic cancer in the future. Fig. 1: Telomerase presence and telomere maintenance in the pancreas. The development of telomerase expression and ...